Screening Recommendations for a 17-Year-Old Adolescent
Yes, a 17-year-old should be screened for anxiety and depression, but the evidence does not support routine screening for lipid levels, CBC, CMP, thyroid function, or A1c in an otherwise healthy adolescent without specific risk factors.
Mental Health Screening (Recommended)
Depression Screening
- Universal screening for depression is recommended for all adolescents aged 12-18 years 1
- The PHQ-2 or PHQ-9 are validated tools for primary care settings 1
- PHQ-9 with cutoff ≥11: sensitivity 89.5%, specificity 77.5%
- PHQ-2 with cutoff ≥3: sensitivity 73.7%, specificity 75.2%
- Implementation data shows 65.8% of adolescents with primary care visits complete screening, with 9.7% screening positive 2
Anxiety Screening
- Universal screening for anxiety is recommended for adolescents aged 8-18 years 3
- This is a 2022 USPSTF Grade B recommendation with moderate certainty of net benefit 3
- Multiple validated screening instruments exist with sensitivity ranging 0.34-1.00 and specificity 0.47-0.99 4
Clinical Pearl: Both depression and anxiety screening should be performed as part of routine preventive care visits. Positive screens require further diagnostic evaluation and consideration of evidence-based treatments (CBT or pharmacotherapy) 1, 4.
Metabolic and Laboratory Screening (Generally NOT Recommended)
Lipid Screening
- The USPSTF gives an "I" statement (insufficient evidence) for universal lipid screening in children and adolescents ≤20 years 5
- This means routine screening is not recommended for healthy 17-year-olds without risk factors
- Consider selective screening only if:
- Family history of premature cardiovascular disease
- Family history of familial hypercholesterolemia
- Obesity or other cardiovascular risk factors
Hemoglobin A1c and Diabetes Screening
- No evidence supports universal A1c screening in healthy adolescents 6
- Risk-based screening is appropriate only for adolescents with:
- Overweight/obesity (BMI ≥85th percentile)
- Additional risk factors (family history, signs of insulin resistance, PCOS)
- When indicated, screening options include fasting glucose, OGTT, or A1c, though none are validated specifically in pediatric populations 6
Thyroid Function Tests
- No guideline supports routine thyroid screening in asymptomatic adolescents
- While thyroid dysfunction can occur in depression patients 7, this does not justify universal screening
- Consider only with specific clinical indicators (growth concerns, symptoms of thyroid disease, family history)
CBC and CMP
- No evidence supports routine CBC or CMP screening in healthy 17-year-olds
- These should be ordered only when clinically indicated by symptoms, physical findings, or specific medical conditions
Common Pitfalls to Avoid
- Over-screening: Ordering "routine labs" without clinical indication wastes resources and may lead to false positives requiring unnecessary follow-up
- Under-screening mental health: Depression and anxiety screening have strong evidence but are often overlooked in busy primary care settings
- Confusing risk-based with universal screening: Lipid and diabetes screening require specific risk factors to justify testing
Practical Implementation Algorithm
For every 17-year-old at a preventive visit:
- ✅ Screen for depression (PHQ-2 or PHQ-9)
- ✅ Screen for anxiety (validated screening tool)
- ❌ Do NOT routinely order lipids, A1c, thyroid, CBC, or CMP
Add selective screening only if risk factors present:
- Lipids: if family history of early CVD or familial hypercholesterolemia
- A1c/glucose: if overweight/obese with additional diabetes risk factors
- Thyroid: if symptoms or strong family history
- CBC/CMP: if specific clinical indication